Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tosedostat

EU orphan designation number: EU/3/09/659   
Active ingredient: Tosedostat
Indication: Treatment of acute myeloid leukaemia
Sponsor: Chroma Therapeutics Ltd
93 Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2009 Centralised Orphan - Designation EMEA/OD/028/09 (2009)6033 of 24/07/2009